ARTICLE | Company News
Open Monoclonal Technology, Celgene deal
March 30, 2015 7:00 AM UTC
OMT granted Celgene non-exclusive, worldwide rights to use OmniRat, OmniMouse and OmniFlic platforms to discover and generate human antibodies against undisclosed targets. Celgene will have rights to ...